ProLectin-M

N/A

Report date: 2024/11/26 20:00:06

Base Information

Drug NameProLectin-M
Drug Alias NameGalactomannan (Bioxytran)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Cytokine Release SyndromeInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBioXyTran Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioXyTran Inc
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Cytokine Release Syndrome

Other Information

ATC CodeN/A
Related LinksDrugBank